Cefdinir Powder, For Suspension
Product Images NDC 68071-3403

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 68071-3403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3403 1)

Pdp (68071 3403 1)
Label for Cefdinir 250 mg/5 mL oral suspension powder in a 100 mL bottle, manufactured by Lupin Limited in India and packaged by NuCare Pharmaceuticals, Inc. The label includes lot numbers, expiration dates, serial numbers, storage instructions (68-77°F), and a warning to keep out of reach of children. The product is prescription only (Rx Only).*
FDA Label Image

Cefdinir (9ecd5d81 Ece0 4a98 9e1a 28651be48f75 01)

Cefdinir (9ecd5d81 Ece0 4a98 9e1a 28651be48f75 01)
Chemical structure diagram of the active ingredient Cefdinir, showing its molecular framework including rings, amine, and carboxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.